Offer - Urjas Oil for just ₹ 1
Glimiprime M 1 Tablet is a commercial drug that is prescribed in the form of Tablet. Diabetes are some of its major therapeutic uses. Secondary and off-label uses of Glimiprime M 1 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Glimiprime M 1 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Glimiprime M 1 Tablet include Headache, Nausea or vomiting, Dizziness. Some other side effects of Glimiprime M 1 Tablet have been listed ahead. These side effects of Glimiprime M 1 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Glimiprime M 1 Tablet's effect during pregnancy is Unknown and Safe while nursing. It is important to know if Glimiprime M 1 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glimiprime M 1 Tablet related warnings section.
Glimiprime M 1 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Kidney Disease, Liver Disease are examples of such conditions. The section on Glimiprime M 1 Tablet contraindications lists all such conditions.
Additionally, Glimiprime M 1 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Glimiprime M 1 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Glimiprime M 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimiprime M 1 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Glimiprime M in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Glimiprime M 1 Tablet safe during breastfeeding?
Breastfeeding women can safely use Glimiprime M.
What is the effect of Glimiprime M 1 Tablet on the Kidneys?
Kidney can be affected by Glimiprime M. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glimiprime M 1 Tablet on the Liver?
Glimiprime M may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimiprime M 1 Tablet on the Heart?
Glimiprime M is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glimiprime M 1 Tablet unless your doctor advises you to do so -
Is this Glimiprime M 1 Tablet habit forming or addictive?
No, there is no any evidence that Glimiprime M 1 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Glimiprime M 1 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Glimiprime M 1 Tablet only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Glimiprime M 1 Tablet for mental disorders.
Interaction between Food and Glimiprime M 1 Tablet
There is no information on the effects of taking Glimiprime M 1 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimiprime M 1 Tablet
It is difficult to say anything about the effect of Glimiprime M 1 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826